Prevalence of positive ppd in a cohort of rheumatoid arthritis patients

Rheumatology International

Volumn 30, Issue 5, 2010, Pages 613-616

  Tamborenea, Maria Natalia ^a   Tate, Guillermo ^a   Mysler, Eduardo ^a   Debonis, Jose ^a   Schijedman, Adrian ^a  

^a OMI Organizacion Medica de Investigacion   (Argentina)

Author keywords

Anergic ppd; Latent tuberculosis; Positive ppd; Rheumatoid arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; LEFLUNOMIDE; MEPREDNISONE; METHOTREXATE; RHEUMATOID FACTOR; STEROID; TUBERCULIN;

ADULT; AGED; ANAMNESIS; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; FALSE NEGATIVE RESULT; FEMALE; HUMAN; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKIN INDURATION; TUBERCULIN TEST;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARGENTINA; ARTHRITIS, RHEUMATOID; BIOLOGICAL PRODUCTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; ISOXAZOLES; LATENT TUBERCULOSIS; LOGISTIC MODELS; MALE; METHOTREXATE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; STEROIDS; TREATMENT OUTCOME; TUBERCULIN TEST; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951023289     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1027-z     Document Type: Article

References (20)

1. Furst DE, Schiff MH, Fleischmann RM, Strand V, Birbara CA, Compagnone D et al (2003) Adalimumab, a fully human anti tumor necrosis factor alpha monoclonal antibody, and concomitant estándar antirheumatic therapy for treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Artritis). J Rheumatol 30:2563-2571
2. Klareskog L, Van Der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M et al (2004) Therapeutic effects of the combination of etanercept and methotrexate compared with each alone in patients with rheumatoid arthritis: double blinded randomised controlled trial. Lancet 343:1594-1602
3. Lipsky PE, Van der Heijde DM, St Clair EW, Furst DE, Breedvelved FC, Kalden JR et al (2000) InXiximab and methotrexate in the treatment of rheumatoid arthritis. Anti tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N Engl J Med 342:763-769. doi:10.1056/ NEJM200003163421103
4. Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, Van Vollenhoven R et al (2006) The Premier Study: a multicenter, randomized, double blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 54:26-37. doi:10.1002/art.21519 (Pubitemid 43122183)
5. Genovese MC, Bothon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH et al (2002) Etanercept versus methotrexate in patients with early rheumatoid arthritis: two years radiographic and clinical outcomes. Arthritis Rheum 46:1443-1450. doi:10.1002/ art.10308
6. Joseph K, Gershon S, Wise PR, Mirabile E et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N Engl J Med 345:1098-1104. doi:10.1056/ NEJMoa011110
7. Imperato A, Smiles S, Abramson SB (2004) Long-term risks associated with biologic response modiWers used in rheumatic diseases. Curr Opin Rheumatol 16:199-205. doi:10.1097/00002281- 200405000-200500006
8. Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Coster L et al (2005) Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. Arthritis Rheum 52(7):1986-1992. doi:10.1002/art.21137 (Pubitemid 40994319)
9. Jacobs M, Togbe D, Fremond C et al (2007) Tumor necrosis factor is critical to control tuberculosis infection. Microbes Infect 9:623-628. doi:10.1016/j.micinf.2007.02.002 (Pubitemid 46628779)
10. Hamdi H, Marieta X, Godoy V et al (2006) Inhibition of antituberculosis T Lymphocyte function with tumour necrosis factor antagonists. Arthritis Res Ther 8:R114
11. Obrador A, San Roman LA, Muñoz P, Gassull MA et al (2003) Guia de Consenso sobre tuberculosis y tratamiento de la enfermedad inflamatoria intestinal con infliximab. Gastroenterol Hepatol 26(1):29-33. doi:10.1157/13042212 (Pubitemid 36168874)
12. Ledingham J, Wilkinson C, Deighton C (2005) British Thoracic Society recommendations for assessing risk and managing tuberculosis in patients due to Stara anti-TNF alpha treatments. Rheumatology 44:1205-1206. doi:10.1093/ rheumatology/kei103 (Pubitemid 41487949)
13. Furst DE, Breedveld FC, Kalden JR et al (2006) Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006. Ann Rheum Dis 65(suppl III):iii2-iii15. doi:101136/ ard2006.061937
14. Corrigall VM, Garyfallos A, Panayi GS (1999) The relative proportions of secreted interleukin-2 and interleukin-10 determine the magnitude of rheumatoid arthritis T cell proliferation to the recall antigen tuberculin puriWed protein derivative. Rheumatol 38:1203-1207. doi:10.1093/rheumatology/38.12.1203
15. Loza E, Alen J, Canto F, Alarcon G (2005) Artritis Reumatoide. In: Ramos Casal M, Carrasco M, Salazar J (eds) Enfermedades Autoinmunes sistémicas y reumatológicas. Masson, Barcelona, pp 369-399
16. Fraser P (1999) Micobacterias. In: Fraser RS, Muller NL, Colman N, Pare PD (eds) Diagnóstico de las Enfermedades del tórax, Ed 4°. WD Sounders, Philadelphia, pp 790-866
17. Gil Germán, Neira O, Marcone P, Sabagh E (2006) Tuberculine reactivity in chilean RA patients (abstract). J Clin Rheumatol 12(Suppl 4):S8
18. Ponce de León D, Acevedo-Vásquez E, Sánchez-Torres A, Cucho M et al (2005) Attenuated response to puriWed protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis. Ann Rheum Dis 64:1360-1361. doi:10.1136/ard.2004.029041 (Pubitemid 41206259)
19. Matulis G, Juni P, Villiger PM et al (2008) Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of mycobacterium tuberculosis antigenspecific interferon assay. Ann Rheum Dis 67(1):84-90
20. Small PM, Fujiwara PI (2001) Management of tuberculosis in the United States. N Engl J Med 345(3):189-200